LEPU BIO-B (02157) Announces February 2026 Equity Status with No Change in Share Capital
Bulletin Express
Mar 05
Lepu Biopharma Co., Ltd. (stock code: 02157) reported that as of 28 February 2026, its authorized share capital remained at 1.80 billion shares, each with a par value of RMB1, totaling RMB1.80 billion. The issued share capital was also unchanged at 1.80 billion shares, with zero shares held as treasury and a maintained public float of 25.00%.
No activity was recorded for share options, warrants, convertible instruments, or other agreements to issue shares during the reporting period. The company confirmed compliance with applicable listing and regulatory requirements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.